BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HRS-3738 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HRS-3738\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05363800-3421@assetmemo.bio
DTSTAMP:20261121T010124Z
DTSTART;VALUE=DATE:20261230
DTEND;VALUE=DATE:20261231
SUMMARY:HRS-3738: Phase 1 readout est. (NCT05363800)
DESCRIPTION:HRS-3738\, phase 1\, Multiple Myeloma.\nStudy: Phase I Study of
  HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple 
 Myeloma\nEstimated primary completion: 30 December 2026. This is a Clinica
 lTrials.gov estimate\, not a confirmed readout date\, and it can move.\nDr
 ug page: https://assetmemo.bio/drug/hrs-3738#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT05363800
URL:https://assetmemo.bio/drug/hrs-3738#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
